{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:45:34Z","timestamp":1791557134571,"version":"4.3.4"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["SB\/SO\/HS\/014\/2014"],"award-info":[{"award-number":["SB\/SO\/HS\/014\/2014"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jep.2017.12.015","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T23:08:52Z","timestamp":1513292932000},"page":"42-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"special_numbering":"C","title":["Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Atish Kumar","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagnehswar","family":"Dandapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Chandra","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kanhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2017.12.015_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-8993(97)01505-9","article-title":"Crocin antagonizes ethanol inhibition of NMDA receptor-medicated responces in rat hippocampal neurons","volume":"787","author":"Abe","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.2042-7158.2011.01309.x","article-title":"Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease","volume":"63","author":"Abuznait","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2017.01.049","article-title":"Crocin improves spatial learning and memory deficits in the Morris water maze via attenuating cortical oxidative damage in diabetic rats","volume":"642","author":"Ahmadi","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2009.06228.x","article-title":"The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta(1-42) peptide","volume":"110","author":"Albani","year":"2009","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.jep.2017.12.015_bib5","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jep.2017.12.015_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2463\/mrms.9.95","article-title":"Amyloid imaging using high-field magnetic resonance","volume":"9","author":"Amatsubo","year":"2010","journal-title":"Magn. Reson. Med. Sci."},{"issue":"5","key":"10.1016\/j.jep.2017.12.015_bib7","first-page":"392","article-title":"Effects of crocin and safranal, saffron constituents, on the formalininduced orofacial pain in rats","volume":"5","author":"Amir","year":"2015","journal-title":"Avicenna J. Phytomed."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib8","doi-asserted-by":"crossref","first-page":"e54887","DOI":"10.1371\/journal.pone.0054887","article-title":"Neurotrophic and neuroprotective actions of (-) and (+)-Phenserine, candidate drugs for Alzheimer's Disease","volume":"8","author":"Anna","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2017.12.015_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.1980.176.10.1061","article-title":"Pharmacotherapeutics of the newer tetracyclines","volume":"176","author":"Aronson","year":"1980","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.jep.2017.12.015_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ptr.1749","article-title":"Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents","volume":"19","author":"Assimopolou","year":"2005","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4522(00)00180-9","article-title":"Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors","volume":"99","author":"Barnes","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jep.2017.12.015_bib12","series-title":"Alzhemeir Disease. from Molecular Biology to Therapy","author":"Becker","year":"1997"},{"key":"10.1016\/j.jep.2017.12.015_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ptr.2650090206","article-title":"Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats","volume":"9","author":"Bhattacharya","year":"1995","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JAD-142421","article-title":"Nasal application of the galantamine pro-drug memogain slows down plaque deposition and ameliorates behavior in 5X familial Alzheimer's disease mice","volume":"46","author":"Bhattacharya","year":"2015","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0028-3908(91)90005-V","article-title":"Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice","volume":"30","author":"Bickel","year":"1991","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/GIM.0b013e31816b64dc","article-title":"Genetic aspects of Alzheimer disease","volume":"10","author":"Bird","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3565(25)12928-5","article-title":"Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine","volume":"277","author":"Bores","year":"1996","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(89)90385-3","article-title":"Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels","volume":"166","author":"Bormann","year":"1989","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1527-3458.2001.tb00205.x","article-title":"Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies","volume":"7","author":"Braida","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jep.2017.12.015_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-1047(93)91159-K","article-title":"Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergicmechanisms","volume":"59","author":"Brioni","year":"1993","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.jep.2017.12.015_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(95)11928-P","article-title":"Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats","volume":"197","author":"Carfagna","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0197-0186(99)00074-1","article-title":"Nicergoline stimulates protein kinase C mediated \u03b1-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cells","volume":"35","author":"Cedano-Minguez","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jep.2017.12.015_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2007.09.023","article-title":"Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes)","volume":"578","author":"Chang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1037\/a0020050","article-title":"Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice","volume":"124","author":"Chang-Mu","year":"2010","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2017.09.015","article-title":"(-)-Phenserine inhibits neuronal apoptosis following ischemia\/reperfusion injury","volume":"1677","author":"Chang","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.reprotox.2009.07.004","article-title":"Impact effects of puerarin on mouse embryonic development","volume":"28","author":"Chen","year":"2009","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0091-3057(97)00601-1","article-title":"Comparative studies of Huperzine A, E2020, and Tacrine on behavior and cholinesterase activities","volume":"60","author":"Cheng","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/rej.2010.1094","article-title":"Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia\/reperfusion injury via the redox-sensitive protein kinase C-\u03b5\/mK(ATP) pathway in rats","volume":"14","author":"Chiu","year":"2011","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.jep.2017.12.015_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archpsyc.57.2.157","article-title":"Extended-release physostigmine in Alzheimer disease. A multicenter, double-blind, 12-week study with dose enrichment","volume":"57","author":"Christopher","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jep.2017.12.015_bib30","first-page":"CD001499","article-title":"Physostigmine for Alzheimer's disease","volume":"2","author":"Coelho","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib31","first-page":"55","article-title":"A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease","volume":"1","author":"Corey-Bloom","year":"1998","journal-title":"Int. J. Geriatr. Psychopharmacol."},{"issue":"6075","key":"10.1016\/j.jep.2017.12.015_bib32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jep.2017.12.015_bib33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0024-3205(98)00082-4","article-title":"Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study","volume":"62","author":"Cutler","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.abb.2008.09.006","article-title":"Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats","volume":"480","author":"De Almeida","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-3057(93)90508-Q","article-title":"Effects of lobeline, a nicotinic receptor agonist, on learning and memory","volume":"45","author":"Decker","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/jamaneurol.2013.6031","article-title":"Environmental exposures and the risk for Alzheimer Disease","volume":"71","author":"DeKosky","year":"2014","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.nbd.2010.07.002","article-title":"Tetracycline and its analogues protect Caenorhabditis elegans from \u03b2 amyloid-induced toxicity by targeting oligomers","volume":"40","author":"Diomede","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib38","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mnfr.201300130","article-title":"Curcumin protects neuronal-like cells against acrolein by restoring Akt and redox signaling pathways","volume":"57","author":"Doggui","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2011.05.120","article-title":"Attenuation of neurodegenerative phenotypes in Alzheimer-like presenilin 1\/presenilin 2 conditional double knockout mice by EUK1001, a promising derivative of xanomeline","volume":"410","author":"Dong","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2017.12.015_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2307\/533198","article-title":"Wichita tales","volume":"15","author":"Dorsey","year":"1902","journal-title":"J. Orig. J. Am. Folk-Lore"},{"key":"10.1016\/j.jep.2017.12.015_bib41","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u02bcs disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jep.2017.12.015_bib42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.jep.2017.12.015_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02245293","article-title":"Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease","volume":"108","author":"Ebmeier","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jep.2017.12.015_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161212798919075","article-title":"Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease","volume":"18","author":"Fei","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jep.2017.12.015_bib45","first-page":"986","article-title":"Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation","volume":"30","author":"Feng","year":"2009","journal-title":"Neuro-Toxicology"},{"key":"10.1016\/j.jep.2017.12.015_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(98)00696-7","article-title":"Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo","volume":"360","author":"Ferger","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.jep.2017.12.015_bib47","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(04)90172-5","article-title":"Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease","volume":"26","author":"Finkel","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.1998.00139.x","article-title":"Milk thistle (Silybum marianum) for the therapy of liver disease","volume":"93","author":"Flora","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jep.2017.12.015_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2165\/00002512-199609010-00006","article-title":"Galantamine","volume":"1","author":"Fulton","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jep.2017.12.015_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2011.05.012","article-title":"Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficts induced by chronic stress in rats","volume":"667","author":"Gadrdoost","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneur.57.6.824","article-title":"Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study","volume":"57","author":"Ganguli","year":"2000","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.jep.2017.12.015_bib52","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1089\/ars.2010.3681","article-title":"Astrocytic redox remodeling by amyloid beta peptide","volume":"14","author":"Garg","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jep.2017.12.015_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin new and emerging applications in medicine","volume":"14","author":"Gazak","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ptr.2650030510","article-title":"Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera","volume":"3","author":"Ghosal","year":"1989","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0197-0186(97)00124-1","article-title":"Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications","volume":"32","author":"Giacobini","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jep.2017.12.015_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0928-4257(98)80034-X","article-title":"Cholinergic foundations of Alzheimer's disease therapy","volume":"92","author":"Giacobini","year":"1998","journal-title":"J. Physiol. Paris."},{"key":"10.1016\/j.jep.2017.12.015_bib57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00023210-199401030-00008","article-title":"Velnacrine in Alzheimer's disease: an initial appraisal of its clinical potential","volume":"1","author":"Goa","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jep.2017.12.015_bib58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2009-1063","article-title":"Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease","volume":"17","author":"Grossi","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib59","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1533317510385808","article-title":"Reviews: effects of transdermal rivastigmine on ADAScog items in mild-to-moderate Alzheimer's disease","volume":"25","author":"Grossberg","year":"2010","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.jep.2017.12.015_bib60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/cbdv.201000269","article-title":"Huperzine A as potential treatment of Alzheimer's disease: an assessment on chemistry pharmacology, and clinical studies","volume":"8","author":"Ha","year":"2011","journal-title":"Chem. Biodiver."},{"key":"10.1016\/j.jep.2017.12.015_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"Curcumin and Alzheimer's disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib62","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jep.2012.11.036","article-title":"Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats","volume":"145","author":"Han","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib63","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1248\/bpb.24.1165","article-title":"Inhibitory action of Oren- gedoku-to extract on enzymatic lipid per oxidation in rat liver microsomes","volume":"24","author":"Hayashi","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jep.2017.12.015_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/157015910792246137","article-title":"Anti-amyloidogenic and antiapoptotic role of melatonin in Alzheimer disease","volume":"8","author":"He","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature09325","article-title":"Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease","volume":"467","author":"He","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002130050931","article-title":"Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease","volume":"143","author":"Heidi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jep.2017.12.015_bib67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","article-title":"Meta-analysis of the acute effects of nicotine and smoking on human performance","volume":"210","author":"Heishman","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib68","first-page":"22","article-title":"Effect of silymarin in intrahepatic cholestasis of pregnancy (preliminary communication)","volume":"47","author":"Hernandez","year":"1982","journal-title":"Rev. Chil. Obstet. Ginecol."},{"issue":"5","key":"10.1016\/j.jep.2017.12.015_bib69","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/PL00005296","article-title":"Idebenone protects hippocampal neurons against amyloid beta-peptide-induced neurotoxicity in rat primary cultures","volume":"358","author":"Hirai","year":"1998","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib70","first-page":"286","article-title":"Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid- peptide in patients with Alzheimer's disease","volume":"920","author":"Hock","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib71","first-page":"1260","article-title":"Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors","volume":"38","author":"Horti","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1142\/S0192415X00000441","article-title":"Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats","volume":"28","author":"Hou","year":"2000","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000085382","article-title":"Natural products and derivatives affecting neurotransmissions relevant to Alzheimer's and Parkinson's disease","volume":"14","author":"Houghton","year":"2005","journal-title":"Neuro Signals"},{"key":"10.1016\/j.jep.2017.12.015_bib74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1039\/b508966m","article-title":"Acetylcholinesterase inhibitors from plants and fungi","volume":"23","author":"Houghton","year":"2006","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jep.2017.12.015_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2007.11.013","article-title":"Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways","volume":"580","author":"Hu","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib76","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3892\/mmr.2014.1999","article-title":"Berberine induces double strand DNA breaks in Rev3 deficient cells","volume":"9","author":"Hu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jep.2017.12.015_bib77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00001756-199502000-00019","article-title":"Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase","volume":"6","author":"Ikari","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.jep.2017.12.015_bib78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0223-5234(01)01222-3","article-title":"Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands","volume":"36","author":"Imming","year":"2001","journal-title":"Eur. J. Med. Chem."},{"issue":"202","key":"10.1016\/j.jep.2017.12.015_bib79","first-page":"1","article-title":"Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jep.2017.12.015_bib80","first-page":"169","article-title":"Comparison of the effect of TAK-147 (zanapezil) and E-2020 (donepezil) on extracellular acetylcholine level and blood flow in the ventral hippocampus of freely moving rats","volume":"1012","author":"Izzettin","year":"2004","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.33549\/physiolres.931449","article-title":"Importance and prospects for design of selective muscarinic agonists","volume":"57","author":"Jakubik","year":"2008","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib82","first-page":"169","article-title":"First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease","volume":"2","author":"James","year":"2016","journal-title":"Alzheimers Dement. TRCI"},{"issue":"6","key":"10.1016\/j.jep.2017.12.015_bib83","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/ajhp\/54.6.692","article-title":"Probable interaction between warfarin and ginseng","volume":"54","author":"Janetzky","year":"1997","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib84","first-page":"61","article-title":"The traditional uses and pharmacological effects of different parts Berberis Vulgaris (berberine) in Iran","volume":"1","author":"Javadzadeh","year":"2013","journal-title":"Sci. Agric."},{"key":"10.1016\/j.jep.2017.12.015_bib85","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Jeff","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jep.2017.12.015_bib86","series-title":"Effects of Salvia miltiorrhiza after Accute Myocardial Infarction in Rats. Novel Compounds from Natural Products in the New Millennium: Potential and Challenges","first-page":"183","author":"Ji","year":"2004"},{"key":"10.1016\/j.jep.2017.12.015_bib87","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.2042-7158.2012.01529.x","article-title":"Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signaling pathways","volume":"64","author":"Jia","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib89","first-page":"78","article-title":"Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden","volume":"3","author":"Johnsson","year":"2005","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.jep.2017.12.015_bib90","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.7b00071","article-title":"Effect of the biphenyl neolignan honokiol on A\u03b242-induced toxicity in Caenorhabditis elegans, A\u03b242 fibrillation, cholinesterase activity, DPPH radicals, and iron(II) chelation","author":"Kantham","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib91","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1248\/bpb.30.514","article-title":"Cerebral protective and cognition-improving effects of sinapic acid in rodents","volume":"30","author":"Karakida","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jep.2017.12.015_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib93","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3565(24)36533-4","article-title":"Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats","volume":"280","author":"Kato","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(98)00943-4","article-title":"Tak-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons","volume":"260","author":"Kato","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib95","first-page":"30","article-title":"Effects of saffron and its active constituents, crocin and safranal, on prevention of indomethacin induced gastric ulcers in diabetic and nondiabetic rats","volume":"8","author":"Kianbakht","year":"2009","journal-title":"J. Med. Plants"},{"key":"10.1016\/j.jep.2017.12.015_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vph.2007.04.007","article-title":"Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages","volume":"47","author":"Kim","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib97","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","article-title":"Naturally occurring phytochemicals for the prevention of Alzheimer's disease","volume":"112","author":"Kim","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2017.12.015_bib98","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2010.03.012","article-title":"Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice","volume":"59","author":"Kim","year":"2010","journal-title":"Neuropharmacol"},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib99","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1254\/jjp.37.300","article-title":"Effect of idebenone (CV-2619) on memory impairment observed in passive avoidance task in rats with cerebral embolization","volume":"37","author":"Kiyota","year":"1985","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(02)00050-5","article-title":"A\u03b2 toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets","volume":"41","author":"Klein","year":"2002","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.jep.2017.12.015_bib101","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/13543784.16.7.1087","article-title":"Phenserine","volume":"16","author":"Klein","year":"2007","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.jep.2017.12.015_bib102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1007515318434","article-title":"Protective effect of Oren-gedoku-to against induction of neuronal death by transient cerebral ischemia in the C57BL\/6 mouse","volume":"25","author":"Kondo","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib103","first-page":"91","article-title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","volume":"43","author":"Kornhuber","year":"1994","journal-title":"Neural Transm."},{"key":"10.1016\/j.jep.2017.12.015_bib104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-2999(99)00876-6","article-title":"Inhibitory effect of orally administered donepezil hydrochloride (E2020) a novel treatment for Alzheimer's disease on cholinesterase activity in rats","volume":"389","author":"Kosasa","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-2006-960916","article-title":"Antiplatelet components in Panax ginseng","volume":"56","author":"Kuo","year":"1990","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2017.12.015_bib106","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2009.02052.x","article-title":"Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease","volume":"63","author":"Kurz","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jep.2017.12.015_bib107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2010.09.038","article-title":"Effects of Berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease","volume":"486","author":"Kwon","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib108","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1371\/journal.pone.0107129","article-title":"Mitochondria and NMDA receptor dependent toxicity of Berberine sensitizes neurons to glutamate and rotenone injury","volume":"9","author":"Kysenius","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2017.12.015_bib109","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/jnp.2010.22.1.8","article-title":"Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data","volume":"22","author":"Lauterbach","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.jep.2017.12.015_bib110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-2004-827207","article-title":"Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s","volume":"70","author":"Lee","year":"2004","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib111","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2012.08.015","article-title":"Neuroprotective effect of sinapic acid in a mouse model of amyloid ??1-42 protein-induced Alzheimer's disease","volume":"103","author":"Lee","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib112","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ptr.4740","article-title":"Ethanol extract of Magnolia officinalis prevents lipopolysaccharide induced memory deficiency via its antineuroinflammatory and antiamyloidogenic effects","volume":"27","author":"Lee","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib113","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1471-4159.2003.01526.x","article-title":"Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons","volume":"84","author":"Li","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2017.12.015_bib114","first-page":"861","article-title":"Effects of Tanshinone on neuropathological changes induced by amyloidpeptide 1-40 injection in rat hippocampus","volume":"25","author":"Li","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jep.2017.12.015_bib115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","article-title":"Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration","volume":"566","author":"Li","year":"2004","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.jep.2017.12.015_bib116","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1248\/bpb.30.847","article-title":"Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats","volume":"30","author":"Li","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jep.2017.12.015_bib117","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2010.09.045","article-title":"Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo","volume":"649","author":"Li","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib118","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.lfs.2012.08.028","article-title":"Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Abeta stimulated THP-1 supernatant and the involvement of p38 pathway activation","volume":"91","author":"Li","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.brainresbull.2012.05.002","article-title":"Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Abeta1-40-stimulated THP-1 monocytes","volume":"88","author":"Li","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib120","first-page":"1000108","article-title":"Brain metabolomics study on the protective effects of ginsenosides Rg1 and Rb1 in an Alzheimer's disease mouse model","volume":"1","author":"Li","year":"2015","journal-title":"Pharm. Anal. Chem. Open"},{"key":"10.1016\/j.jep.2017.12.015_bib121","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0031-1299763","article-title":"Protective effect of Puerarin on beta amyloid induced neurotoxicity in rat hippocampal neurons","volume":"62","author":"Lin","year":"2012","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib122","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2003-37707","article-title":"Honokiol ameliorates cerebral infarction from ischemiareperfusion injury in rats","volume":"69","author":"Liou","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2017.12.015_bib123","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0022-3565(25)21303-9","article-title":"RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization","volume":"279","author":"Lippiello","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib124","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0006-2952(94)90187-2","article-title":"Magnolol and honokiol from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation","volume":"47","author":"Lo","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib125","first-page":"11","article-title":"Improving effect of huperzine A in aged rats and adult rats with experimental cognitive impairment","volume":"9","author":"Lu","year":"1988","journal-title":"Acta Pharm. Sin."},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00210-003-0802-8","article-title":"The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus","volume":"368","author":"Lu","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib127","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.109.155069","article-title":"Silibinin attenuates amyloid beta (25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice","volume":"331","author":"Lu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phrs.2007.07.006","article-title":"Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study","volume":"56","author":"Luigia","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1039\/b409720n","article-title":"The Lycopodium alkaloids","volume":"21","author":"Ma","year":"2004","journal-title":"Nat. Prod. Rep."},{"issue":"1\u20132","key":"10.1016\/j.jep.2017.12.015_bib131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12031-009-9269-5","article-title":"Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy","volume":"40","author":"Maelicke","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib132","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1021\/jf061932a","article-title":"Inhibitory activity on amyloid-\u03b2 aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents","volume":"54","author":"Magdalini","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib133","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/j.1552-4604.1998.tb04467.x","article-title":"Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers","volume":"38","author":"Mant","year":"1998","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib134","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M508246200","article-title":"Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides","volume":"280","author":"Marambaud","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2009.09.107","article-title":"Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice","volume":"1305","author":"Matsui","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib136","first-page":"15","article-title":"Nature's medicine for memory loss","volume":"23","author":"McCaleb","year":"1990","journal-title":"HerbalGram"},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib137","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000051192","article-title":"The clinical trial protocol of the Metrifonate in Alzheimer's Trial (MALT)","volume":"9","author":"McKeith","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"3","key":"10.1016\/j.jep.2017.12.015_bib138","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/jpet.104.068098","article-title":"Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters","volume":"310","author":"Miller","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/nlme.1995.1017","article-title":"The action of arecoline on retrieval and memory storage evaluated in the staircase maze","volume":"63","author":"Molinengo","year":"1995","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.jep.2017.12.015_bib140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jep.2017.12.015_bib141","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s000110050512","article-title":"A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa","volume":"48","author":"Moon","year":"1999","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib142","first-page":"9","article-title":"Air pollution, oxidative stress, and Alzheimer's disease","volume":"2012","author":"Moulton","year":"2012","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"13\u201314","key":"10.1016\/j.jep.2017.12.015_bib143","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0024-3205(97)00038-6","article-title":"Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain","volume":"60","author":"M\u00fcller","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib144","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0197-4580(96)00077-2","article-title":"Effect of Tak-147, A novel AChE inhibitor, on cerebral energy metabolism","volume":"17","author":"Nakayama","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jep.2017.12.015_bib145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.003","article-title":"Anti-inflammatory effects of crocin and crocetin in rats brain microglial cells","volume":"648","author":"Nam","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib146","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00023210-199708030-00008","article-title":"Propentofylline","volume":"8","author":"Noble","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jep.2017.12.015_bib147","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent antifibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2017.12.015_bib148","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/092986706775197962","article-title":"Comparative studies of the antioxidant effects of cis- and trans-resveratrol","volume":"13","author":"Orallo","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib149","first-page":"1155","article-title":"Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis","volume":"10","author":"Oshiro","year":"2011","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0026-895X(25)10925-5","article-title":"[3H] cytisine binding to nicotinic cholinergic receptors in brain","volume":"39","author":"Pabreza","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib151","first-page":"1","article-title":"Amyloid-\u03b2 interaction with mitochondria","volume":"10","author":"Pagani","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib152","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2003.11.061","article-title":"Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice","volume":"999","author":"Paris","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib153","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib154","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2006-957926","article-title":"Novel anti cholinesterase and anti amnesic activities of dehydroevodiamine, a constituent of Evodia ruraecarpa","volume":"62","author":"Park","year":"1996","journal-title":"Planta Med."},{"issue":"6","key":"10.1016\/j.jep.2017.12.015_bib155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jep.2017.12.015_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<1::AID-JNR1>3.0.CO;2-M","article-title":"Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions","volume":"54","author":"Pasinetti","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib157","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbr.2007.06.001","article-title":"Effects of the active constituents of Crocus sativus L., crocins on recognisation and spatial rats memory","volume":"183","author":"Patsikas","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib158","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/JMN:20:3:267","article-title":"Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslatede region: the action of paroxetine and dimercatopropanol","volume":"20","author":"Payton","year":"2003","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.jep.2017.12.015_bib159","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ajhp\/57.6.530","article-title":"Huperzine A","volume":"57","author":"Pepping","year":"2000","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jep.2017.12.015_bib160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.bmb.a072100","article-title":"The cholinergic hypothesis-ten years on","volume":"42","author":"Perry","year":"1986","journal-title":"Br. Med. Bul."},{"key":"10.1016\/j.jep.2017.12.015_bib161","first-page":"777","article-title":"Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy","volume":"58","author":"Piotr","year":"2005","journal-title":"Pharmacol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.jep.2017.12.015_bib162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2007.03.026","article-title":"Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors","volume":"566","author":"Plazas","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.jep.2017.12.015_bib163","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/jf030174a","article-title":"Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry","volume":"51","author":"Prasain","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2832-2-1","article-title":"Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients. Current pharmacologic options for patients with Alzheimer's disease","volume":"2","author":"Reichman","year":"2003","journal-title":"Ann. Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jep.2017.12.015_bib165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors: focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib166","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jm049112h","article-title":"Rational approach to discover multipotent anti-Alzheimer drugs","volume":"48","author":"Rosini","year":"2005","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib167","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1155\/1999\/168023","article-title":"Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease","volume":"11","author":"R\u00f6sler","year":"1998","journal-title":"Behav. Neurol."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib168","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000051188","article-title":"Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials","volume":"9","author":"Rother","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jep.2017.12.015_bib169","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0022-510X(92)90296-W","article-title":"Reversal of cognitive impairment by heptyl-physostigmine, a long-lasting cholinesterase inhibitor, in primates","volume":"107","author":"Rupniak","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2007.08.019","article-title":"Thalidomide inhibition of perturbed vas-culature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer's disease brain","volume":"29","author":"Ryu","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib171","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1021\/bi9617264","article-title":"Nicotine inhibits amyloid formation by the \u03b2-peptide","volume":"35","author":"Salomon","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jep.2017.12.015_bib172","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1476-5381.2012.02112.x","article-title":"Nimodipine inhibits IL-1\u03b2 release stimulated by amyloid b from microglia","volume":"167","author":"Sanz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-1119(02)01092-2","article-title":"Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues","volume":"302","author":"Schaffer","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.jep.2017.12.015_bib174","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0197-0186(96)00025-3","article-title":"Administration of defined extracts from Withania somnifera (Indian ginseng) and shilajit differentially affects cholinergic but not glutamatergic markers in rat brain","volume":"30","author":"Schliebs","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jep.2017.12.015_bib175","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain \u03b17: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"S\u00e9gu\u00e9la","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib176","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0167-4943(92)90060-H","article-title":"Idebenone in senile dementia of Alzheimer type: a multicentre study","volume":"15","author":"Senin","year":"1992","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.jep.2017.12.015_bib177","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","article-title":"Neurotoxic effects of Berberine on long-term L-DOPA administration in 6-hydroxydopaminelesioned rat model of Parkinson's disease","volume":"36","author":"Shin","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib178","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0006-8993(88)90587-2","article-title":"Regional changes in [3H] D-aspartate and [3H] TCP binding sites in Alzheimer's disease brains","volume":"462","author":"Simpson","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2017.12.015_bib179","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1126\/science.351807","article-title":"Physostigmine: improvement of long-term memory processes in normal humans","volume":"201","author":"Sitaram","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.jep.2017.12.015_bib180","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.1997.03540340010004","article-title":"Old herbal Chinese medicine used for fever yields possible new Alzheimer disease therapy","volume":"277","author":"Skolnick","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jep.2017.12.015_bib181","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.1997.03550160083043","article-title":"Diagnosis and treatment of Alzheimer's disease and related disorders","volume":"278","author":"Small","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jep.2017.12.015_bib182","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.bmc.2009.02.016","article-title":"Amphotericin B interactions with soluble oligomers of amyloid Abeta1-42 peptide","volume":"17","author":"Smith","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib183","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1023\/A:1021116502548","article-title":"Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of lowaffinity sites","volume":"24","author":"Squires","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib184","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1523\/JNEUROSCI.23-31-10093.2003","article-title":"Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation","volume":"23","author":"Stevens","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib185","first-page":"138","article-title":"Preliminary phytochemical investigation and antimicrobial activity of Sinapis alba","volume":"1","author":"Sujatha","year":"2013","journal-title":"Sch. J. Appl. Med. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib186","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2010-100306","article-title":"Neuronal calcium signaling, mitochondrial dysfunction and Alzheimer's disease","volume":"20","author":"Supnet","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jep.2017.12.015_bib187","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1021\/jm00024a009","article-title":"Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds","volume":"38","author":"Sugimoto","year":"1995","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jep.2017.12.015_bib188","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1248\/bpb.30.1727","article-title":"Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rats patial cognition in an eight-arm radial maze task","volume":"30","author":"Sun","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jep.2017.12.015_bib189","first-page":"83","article-title":"Crocin enhanced functional recovery after sciatic nerve crush injury in rats","volume":"16","author":"Tamaddonfard","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib190","first-page":"91","article-title":"Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats","volume":"16","author":"Tamaddonfard","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib191","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S1734-1140(13)71485-3","article-title":"Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats","volume":"65","author":"Tamaddonfard","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.jep.2017.12.015_bib192","doi-asserted-by":"crossref","first-page":"17","DOI":"10.31887\/DCNS.2003.5.1\/yptang","article-title":"Genetic studies in Alzheimer's disease","volume":"5","author":"Tang","year":"2003","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib193","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jep.2017.12.015_bib194","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1271\/bbb.62.998","article-title":"4-Hydroxy-3- nitrophenylacetic and sinapic acids as antibacterial compounds from mustard seeds","volume":"62","author":"Tesaki","year":"1998","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.jep.2017.12.015_bib195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1359-6446(03)02685-0","article-title":"Surprising discovery with Alzheimer's medication","volume":"8","author":"Thacker","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jep.2017.12.015_bib196","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1212\/WNL.54.2.421","article-title":"Lu-25-109, a muscarinic agent, fails to improve cognition in Alzheimer's disease","volume":"54","author":"Tlal","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2017.12.015_bib197","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0091-3057(02)00819-5","article-title":"Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats","volume":"73","author":"Tokita","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib198","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0024-3205(01)01390-X","article-title":"Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa","volume":"70","author":"Ueng","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2017.12.015_bib199","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21073","article-title":"Artherosclerosis and risk for dementia","volume":"61","author":"Van","year":"2007","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jep.2017.12.015_bib200","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0090-9556(24)15071-4","article-title":"Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures","volume":"28","author":"Venkataramanan","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jep.2017.12.015_bib201","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1520-6769(200007\/08)27:1<9::AID-NRC2>3.0.CO;2-9","article-title":"Effects of lobeline on spatial learning in C57BL mice","volume":"27","author":"Vicens","year":"2000","journal-title":"Neurosci. Res. Commun."},{"key":"10.1016\/j.jep.2017.12.015_bib202","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jep.2017.12.015_bib203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2165\/00002512-199404060-00006","article-title":"Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease","volume":"4","author":"Wagstaff","year":"1994","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib204","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00702-009-0189-x","article-title":"Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis","volume":"116","author":"Wang","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jep.2017.12.015_bib205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/10286020902843152","article-title":"Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells","volume":"11","author":"Wang","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2121-11-31","article-title":"Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.jep.2017.12.015_bib207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000119366","article-title":"A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease","volume":"36","author":"Weyer","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jep.2017.12.015_bib208","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1614-8","article-title":"Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment","volume":"171","author":"White","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002093-199501002-00002","article-title":"Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications","volume":"9","author":"Whitehouse","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jep.2017.12.015_bib210","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"On behalf of the Galantamine International-1 Study Group: efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jep.2017.12.015_bib211","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/gps.409","article-title":"Galantamine: a randomised, double-blind, dose comparison in patients with Alzheimer's disease","volume":"16","author":"Wilkinson","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jep.2017.12.015_bib212","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2017.12.015_bib213","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1039\/C0NP00027B","article-title":"Natural products as a source of Alzheimer's drug leads","volume":"28","author":"Williams","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jep.2017.12.015_bib214","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3940(03)00125-3","article-title":"The protective effect of ganstigmine against amyloid beta25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition","volume":"341","author":"Windisch","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib215","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1073\/pnas.98.4.2089","article-title":"Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning","volume":"98","author":"Woodruff-Pak","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3\u20134","key":"10.1016\/j.jep.2017.12.015_bib216","first-page":"219","article-title":"Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo","volume":"17","author":"Wu","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2017.12.015_bib217","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10075","article-title":"Huperzine A attenuates amyloid \u00df-peptide fragment 25-35 induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation","volume":"67","author":"Xiao","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib218","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainresbull.2011.03.024","article-title":"Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway","volume":"85","author":"Xing","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jep.2017.12.015_bib219","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0304-3940(02)00830-3","article-title":"Effect of 3-[1-(Phenylmethyl)-4-Piperidinyl]-1-(2,3,4,5-tetrahydro-1h-1-benzazepin-8-Yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats","volume":"331","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib220","first-page":"1327","article-title":"Intervention effect of berberine on expressions of TNF-alpha and receptor type I in Abeta25-35-induced inflammatory reaction in SH-SY5Y cell lines","volume":"38","author":"Xu","year":"2013","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"22","key":"10.1016\/j.jep.2017.12.015_bib221","first-page":"2030","article-title":"Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury","volume":"8","author":"Yan","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jep.2017.12.015_bib222","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib223","first-page":"44","article-title":"Curcumin protects against intracellular amyloid toxicity in rat primary neurons","volume":"5","author":"Ye","year":"2012","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib224","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuint.2010.12.017","article-title":"Silibinin: a novel inhibitor of Abeta aggregation","volume":"58","author":"Yin","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jep.2017.12.015_bib225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156720506779025288","article-title":"The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti-Alzheimer drugs ladostigil and m30","volume":"3","author":"Youdim","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jep.2017.12.015_bib226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4062\/biomolther.2013.044","article-title":"Silibinin inhibits LPS-induced macrophage activation by blocking p38MAPK in RAW264.7 cells","volume":"21","author":"Youn","year":"2013","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jep.2017.12.015_bib227","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1021\/jf802095g","article-title":"Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kB inactivation","volume":"56","author":"Yun","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"8\u20139","key":"10.1016\/j.jep.2017.12.015_bib228","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/BF01291795","article-title":"Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial","volume":"103","author":"Zemlan","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jep.2017.12.015_bib229","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0406361102","article-title":"Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jep.2017.12.015_bib230","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.cellbi.2008.07.006","article-title":"Puerarin protects PC12 cells against beta-amyloid-induced cell injury","volume":"32","author":"Zhang","year":"2008","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jep.2017.12.015_bib231","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2010.09.013","article-title":"Puerarin protects Alzheimer\u02bcs disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways","volume":"46","author":"Zhang","year":"2011","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jep.2017.12.015_bib232","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2012.11.052","article-title":"Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kappaB activation and cytokine production of glial cells","volume":"534","author":"Zhang","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jep.2017.12.015_bib233","first-page":"4497","article-title":"Pharmacological study of nimodipine plus donepezil in treating senile dementia","volume":"9","author":"Zhang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jep.2017.12.015_bib234","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(02)03107-1","article-title":"Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons","volume":"526","author":"Zhou","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jep.2017.12.015_bib235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:31:1-3:205","article-title":"Oxidative imbalance in Alzheimer's disease","volume":"31","author":"Zhu","year":"2005","journal-title":"Mol. Neurobial"},{"issue":"4","key":"10.1016\/j.jep.2017.12.015_bib236","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.bmc.2008.12.067","article-title":"Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jep.2017.12.015_bib237","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2202-12-125","article-title":"Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells","volume":"12","author":"Zhu","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jep.2017.12.015_bib238","article-title":"Nimodipine attenuates tau phosphorylation at Ser396 via miR-132\/GSK-3\u03b2 pathway in chronic cerebral hypoperfusion rats","author":"Zihu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2017.12.015_bib239","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10715762.2012.742518","article-title":"Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3beta\/ Nrf2 signaling pathway","volume":"47","author":"Zou","year":"2013","journal-title":"Free Radic. Res."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874117320779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874117320779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T20:38:06Z","timestamp":1751143086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874117320779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":239,"alternative-id":["S0378874117320779"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2017.12.015","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2017.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}